BioVersys
Basel, CH · 2 known investors
BioVersys is a Swiss pharmaceutical company developing small-molecule drugs with novel modes of action to treat drug-resistant bacterial infections, addressing antimicrobial resistance (AMR). Its pipeline targets serious hospital infections such as A. baumannii, S. aureus, and NTM infections.
BiotechDeep TechHealthtech
Investors · 2
Frequently asked questions
- What does BioVersys do?
- BioVersys is a Swiss pharmaceutical company developing small-molecule drugs with novel modes of action to treat drug-resistant bacterial infections, addressing antimicrobial resistance (AMR). Its pipeline targets serious hospital infections such as A. baumannii, S. aureus, and NTM infections.
- Who are BioVersys's investors?
- BioVersys's investors include AMR Action Fund, StartAngels Network.
- Where is BioVersys headquartered?
- BioVersys is headquartered in Basel, CH.